A Lung Epithelioid Hemangioendothelioma Subtype with YAP1::TFE3 Fusion: A Case Report
International Journal of Surgical Pathology · 2025
DOI: 10.1177/10668969251333124 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Surgical Pathology, 2025. Verfasst von Chuan Xiao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical Univer…. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Hemangioendothelioma, Epithelioid, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Suzhou Science and Technology Plan Project.
Abstract (Originalsprache)
Epithelioid hemangioendothelioma (EHE) is a rare and low-grade malignant endothelial sarcoma. Based on disease-defining mutations, approximately 95% of EHEs have the conventional WWTR1::CAMTA1 gene fusion, while approximately 5% are the Yes-associated protein-1 (YAP1):: transcription factor binding to IGHM enhancer 3 (TFE3) fused tumor subtype according to the World Health Organization classification. Although this tumor type is well recognized, EHE, especially the YAP1 :: TFE3 fused tumor subtype, represents a diagnostic challenge in routine practice due to its rarity and morphologic overlap with other epithelioid tumors, including other benign and malignant epithelioid vascular neoplasms or carcinomas. Here, we highlight the loss of YAP1 C-terminus expression from the nucleus and cytoplasm of tumor cells along with TFE3 positivity and CAMTA1 negativity as a panel of sensitive markers for detecting lung EHE with YAP1 :: TFE3 fusion. We also briefly describe the clinicopathological characteristics of this tumor subtype and detail its relevant differential diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.
ORCID-Profile: Chuan Xiao, Jinghuan Lv
Förderung
- Suzhou Science and Technology Plan Project
Zitieren
APA
Xiao, C., Xu, W., Shen, M., Cao, D., & Lv, J. (2025). A Lung Epithelioid Hemangioendothelioma Subtype with YAP1::TFE3 Fusion: A Case Report. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969251333124
Vancouver
Xiao C, Xu W, Shen M, Cao D, Lv J. A Lung Epithelioid Hemangioendothelioma Subtype with YAP1::TFE3 Fusion: A Case Report. International Journal of Surgical Pathology. 2025. doi:10.1177/10668969251333124
BibTeX
@article{Xiao2025,
author = {Xiao, Chuan and Xu, Weiwei and Shen, Minghong and Cao, Dan and Lv, Jinghuan},
title = {A Lung Epithelioid Hemangioendothelioma Subtype with YAP1::TFE3 Fusion: A Case Report},
journal = {International Journal of Surgical Pathology},
year = {2025},
doi = {10.1177/10668969251333124}
}
EUVIMED